UBE4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.598200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.353000E-01
Normal-vs-Stage2
3.931200E-01
Normal-vs-Stage3
1.074050E-01
Normal-vs-Stage4
9.602000E-01
Stage1-vs-Stage2
9.073200E-01
Stage1-vs-Stage3
7.958000E-02
Stage1-vs-Stage4
4.097200E-01
Stage2-vs-Stage3
7.338200E-02
Stage2-vs-Stage4
2.818800E-01
Stage3-vs-Stage4
4.479800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.325400E-01
Normal-vs-AfricanAmerican
9.161000E-01
Normal-vs-Asian
4.068400E-01
Caucasian-vs-AfricanAmerican
2.527800E-01
Caucasian-vs-Asian
5.348600E-01
AfricanAmerican-vs-Asian
3.156000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.884400E-01
Normal-vs-Female
4.731400E-01
Male-vs-Female
2.735800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.040000E-01
Normal-vs-Age(41-60Yrs)
6.531000E-01
Normal-vs-Age(61-80Yrs)
3.118800E-01
Normal-vs-Age(81-100Yrs)
1.290620E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.707210E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.906600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.431400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.987600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.584220E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.690800E-01
Normal-vs-Daily Drinker
2.720800E-01
Normal-vs-Weekly Drinker
4.377800E-01
Normal-vs-Occasional Drinker
4.330800E-01
Normal-vs-Social Drinker
5.816800E-01
Non Drinker-vs-Daily Drinker
8.789200E-01
Non Drinker-vs-Weekly Drinker
6.232400E-01
Non Drinker-vs-Occasional Drinker
3.929200E-01
Non Drinker-vs-Social Drinker
2.403000E-01
Daily Drinker-vs-Weekly Drinker
5.644800E-01
Daily Drinker-vs-Occasional Drinker
3.516600E-01
Daily Drinker-vs-Social Drinker
2.234000E-01
Weekly Drinker-vs-Occasional Drinker
8.030400E-01
Weekly Drinker-vs-Social Drinker
5.704800E-01
Occasional Drinker-vs-Social Drinker
6.957600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.228200E-02
Normal-vs-Grade 2
1.972280E-02
Normal-vs-Grade 3
2.541700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.087000E-01
Grade 1-vs-Grade 3
1.022610E-01
Grade 1-vs-Grade 4
9.228200E-02
Grade 2-vs-Grade 3
4.050000E-01
Grade 2-vs-Grade 4
1.972280E-02
Grade 3-vs-Grade 4
2.541700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.032200E-01
Normal-vs-NonDiabetic
2.827000E-01
Diabetic-vs-NonDiabetic
2.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.959800E-01
Normal-vs-NoPancreatitis
2.515000E-01
Pancreatitis-vs-NoPancreatitis
2.342200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.031800E-01
Normal-vs-N1
3.836200E-01
N0-vs-N1
9.631000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.560600E-01
Normal-vs-TP53-NonMutant
5.999400E-01
TP53-Mutant-vs-TP53-NonMutant
2.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
